Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
14.25
+1.15 (8.78%)
Nov 3, 2026, 2:36 PM EST - Market open
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Syndax Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $37.27. The average 1-year stock price forecast is 161.54% higher than the current stock price, while the lowest is $23 (+61.40%) and the highest is $57 (+300.00%).
Price Target: $37.27 (+161.54%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 10 | 10 | 10 | 10 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 → $36 | Buy | Reiterates | $38 → $36 | +152.63% | Nov 3, 2026 |
| Citi | Citi | Buy Maintains $57 | Buy | Maintains | $57 | +300.00% | Nov 3, 2026 |
| Barclays | Barclays | Buy Maintains $37 | Buy | Maintains | $37 | +159.65% | Nov 3, 2026 |
| UBS | UBS | Hold Maintains $33 | Hold | Maintains | $33 | +131.58% | Nov 3, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $40 | Buy | Maintains | $40 | +180.70% | Nov 3, 2026 |
Financial Forecast
Revenue This Year
316.36M
from 172.35M
Increased by 83.56%
Revenue Next Year
458.76M
from 316.36M
Increased by 45.01%
EPS This Year
-1.91
from -3.29
EPS Next Year
-0.73
from -1.91
EPS and Forward PE are based on non-GAAP adjusted numbers.